Approval · Notice of Compliance 8758 · 2007
REYATAZ: Notice of Compliance 8758
Issued May 2, 2007
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 8758
- Date
- May 2, 2007
- Company
- Bristol-Myers Squibb CanadaSt-Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New strength - 300mg capsule
- Therapeutic class
- Azapeptide inhibitor of HIV-1 protease
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| REYATAZ | 02294176 | Cancelled Post Market |
Medicinal ingredients
- ATAZANAVIR SULFATE 300 MG per CAP